ALBO
$25.46
Albireo Pharma
($.34)
(1.32%)
ALBO
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($1.27)
Revenue:  $5.02 Mil
Thursday
Feb 24
8:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, November 04, 2021

What do you expect when ALBO reports earnings?
Beat
Meet
Miss

Where is ALBO's stock price going from here?
Up
Flat
Down
Stock chart of ALBO
Analysts
Summary of analysts' recommendations for ALBO
Score
Grade
Pivots
Resistance
$27.05
$26.66
$26.06

$25.67

Support
$25.07
$24.68
$24.08
Tweet
Growth
Description
Albireo Pharma, Inc. is a biopharmaceutical company. It focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo Pharma Inc., formerly known as BIODEL INC., is based in Boston, United States.